Artivion | CRY - Operating Expenses


Artivion reported $111.2M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Abbott USD 11.66B 1.2B Sep/2026
Accuray USD 37.18M 567K Dec/2024
AngioDynamics USD 81.95M 1.68M Sep/2025
Artivion USD 111.2M 9.45M Dec/2025
AtriCure USD 143.94M 3.22M Jun/2026
Baxter International USD 2.68B 3.36B Jun/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Boston Scientific USD 4.2B 49M Jun/2026
Edwards Lifesciences USD 1.22B 87.6M Jun/2026
Inogen USD 49.14M 665K Sep/2024
Integra LifeSciences USD 368.53M 674.84M Sep/2026
J&J USD 18.93B 1.09B Sep/2026
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Orthofix International USD 213.79M 12.36M Dec/2025
Pfizer USD 85.19B 4.91B Jun/2026
ResMed USD 1.01B 83.57M Jun/2026
Stryker USD 4.8B 118M Jun/2026
Tandem Diabetes Care USD 268.35M 3.7M Jun/2026
Teleflex USD 2.9B 179.9M Jun/2026
Terumo JPY 222.33B 46.54B Jun/2026
Trinity Biotech USD 12.38M 2.44M Dec/2025